MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 4, p. 845, doi. 10.1007/s00415-018-8781-3
- By:
- Publication type:
- Article
Works matching AU Thiels, Charlotte
Results: 13
1
2
Evaluating the relationship between psychometric intelligence and cognitive functions in paediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319894365
- By:
- Publication type:
- Article
3
CNS findings in congenital muscular dystrophy 1A (with laminin alpha-2-deficiency).
- Published in:
- Translational Neuroscience, 2011, v. 2, n. 2, p. 138, doi. 10.2478/s13380-011-0020-7
- By:
- Publication type:
- Article
4
Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 6, p. 340, doi. 10.3390/brainsci10060340
- By:
- Publication type:
- Article
5
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
- Published in:
- 2021
- By:
- Publication type:
- journal article
6
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
7
Interval Timing in Pediatric Multiple Sclerosis: Impaired in the Subsecond Range but Unimpaired in the One-Second Range.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.575780
- By:
- Publication type:
- Article
8
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol
- Published in:
- Orphanet Journal of Rare Diseases, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13023-024-03495-1
- By:
- Publication type:
- Article
9
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol
- Published in:
- Orphanet Journal of Rare Diseases, 2025, v. 20, p. 1, doi. 10.1186/s13023-024-03495-1
- By:
- Publication type:
- Article
10
Optical Genome Mapping Reveals Disruption of the RASGRF2 Gene in a Patient with Developmental Delay Carrying a De Novo Balanced Reciprocal Translocation.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
11
Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.
- Published in:
- Human Mutation, 2012, v. 33, n. 3, p. 485, doi. 10.1002/humu.22019
- By:
- Publication type:
- Article
12
A multicenter, matched case–control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany.
- Published in:
- Neurological Research & Practice, 2024, v. 6, n. 1, p. 1, doi. 10.1186/s42466-024-00323-6
- By:
- Publication type:
- Article
13
Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature.
- Published in:
- 2021
- By:
- Publication type:
- journal article